RISE Adult Medication Study

PHASE3CompletedINTERVENTIONAL
Enrollment

267

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 28, 2019

Study Completion Date

August 31, 2019

Conditions
PrediabetesType 2 Diabetes
Interventions
DRUG

Metformin

Titrated to 1000 mg BID

DRUG

Liraglutide

Titrated to 1.8 mg/day

DRUG

Glargine

Titrated to target fasting glucose \<90 mg/dl

DRUG

Placebo

Matching to metformin 1000 mg BI

Trial Locations (4)

46202

Indiana University, Indianapolis

60612

Jesse Brown VA Medical Center, Chicago

60637

University of Chicago, Chicago

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

RISE Study Group

NETWORK

NCT01779362 - RISE Adult Medication Study | Biotech Hunter | Biotech Hunter